Abbott To Unveil New ARCHITECT(R) ci4100(TM) Integrated Immunoassay and
Clinical Chemistry System
When Available in the U.S., ARCHITECT(R) ci4100(TM) Will Complete the
ARCHITECT Family of Products, Providing Improved Productivity for
Low-Volume-Testing Laboratories
WASHINGTON, July 28 /PRNewswire-FirstCall/ -- Abbott (NYSE: ABT) will
preview the new ARCHITECT(R) ci4100(TM) Integrated System at the American
Association of Clinical Chemistry (AACC) Annual Meeting this week. The
ci4100(TM) is an automated diagnostic analyzer that integrates immunoassay and
clinical chemistry testing. Expected to be available in the United States by
mid-2009, subject to regulatory approvals, the ci4100 will expand Abbott's
family of integrated systems, offering low-volume-testing laboratories and
clinics increased productivity and performance.
As low-volume facilities continue to seek efficiency-enhancing solutions,
the ci4100 is designed to deliver improved productivity by providing a large
capacity of up to 85 onboard reagents and 180 samples that can be continuously
loaded and unloaded during the testing process. The ci4100 also will
effectively integrate clinical chemistry and immunoassay testing with an
expansive test menu, while maintaining quick and consistent immediate
turnaround times during both peak and off-peak hours. This helps low to
mid-volume facilities meet the demands of increasing workloads and clinical
requirements. The ci4100 can generate up to 800 clinical chemistry and 100
immunoassay tests per hour.
When available in the United States, the ci4100 will complete the
ARCHITECT family of analyzers. The ARCHITECT system integrates two highly
successful ARCHITECT instruments: the i1000SR immunoassay analyzer and the
c4000 clinical chemistry system, which was developed with Abbott's partner,
Toshiba. Because the ci4100 is based on Abbott's existing ARCHITECT ci8200
and ci16200 integrated platforms, it shares common hardware, software and
reagents. Upon regulatory approval, Abbott will be the only company offering
high, medium and low-volume integrated solutions leveraging the same software,
reagents and sample carriers.
The AACC Annual Meeting is a global meeting that attracts nearly 20,000
attendees from more than 100 countries. The ci4100 is on display in Abbott's
AACC exhibit booth (No. 1507).
About the ARCHITECT Family
With its extensive menu of diagnostic tests, user-friendly software and
advanced sample management capabilities, the ARCHITECT family and the
currently marketed flagship analyzer, ARCHITECT(R) ci8200(R), meet the needs
of today's diagnostics laboratory by enhancing workflow and productivity.
ARCHITECT instruments are designed with laboratory-focused features such
as the capability to prioritize emergency tests, the ability to use common
reagents among platforms and sample monitoring. These features not only
minimize training, but also reduce inventory costs and sample contamination
potential, leading to better results for laboratories, physicians and,
ultimately, patients.
About Abbott's Diagnostics Businesses
Abbott is a global leader in in vitro diagnostics and offers a broad range
of innovative instrument systems and tests for hospitals, reference labs,
molecular labs, blood banks, physician offices and clinics. With more than
65,000 customers in more than 100 countries, Abbott's diagnostic products
offer customers automation, convenience, bedside testing, cost effectiveness
and flexibility. Abbott has helped transform the practice of medical diagnosis
from an art to a science through the company's commitment to improving patient
care and lowering costs. The history of Abbott is filled with examples of
first-of-a-kind diagnostic products and significant technological and research
advancements.
About Abbott
Abbott is a global, broad-based health care company devoted to the
discovery, development, manufacture and marketing of pharmaceuticals and
medical products, including nutritionals, devices and diagnostics. The
company employs more than 68,000 people and markets its products in more than
130 countries.
Abbott's news releases and other information are available on the
company's Web site at HTTP://www.abbott.com.
SOURCE Abbott
Don Braakman of Abbott, +1-847-937-0080
